The finding that IL-33, IL-2 and IL-9 are also elevated in CF patients33, 34 prompted us to evaluate the contribution of cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction on the activation of the inflammatory circuit. The gene discussed is CFTR; the disease is cystic fibrosis.